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Can We Unify the Process?Valentin Fuster, MD, PHDT he biblical story of the Tower of Babel (1), inwhich people could not coexist because ofthe different languages they spoke, provides
a telling analogy for the state of contemporary
clinical practice guideline development. The cardiol-
ogy community and, more importantly, cardiovascu-
lar patients would reap tremendous beneﬁt if there
was a more uniﬁed approach to cross-continental
development of clinical practice guidelines. The
world continues to be “ﬂattened” by heightened com-
munication and interaction through technology,
which should only serve to ease the process of unify-
ing patient management recommendations across
countries and continents.
Although I personally understand that it will be a
huge feat to accomplish this goal, we have a prece-
dent for a successful development and deployment
of clinical guidelines with the 2001 ACC/AHA/ESC
Guidelines for the Management of Patients With
Atrial Fibrillation, which were developed with a
committee of experts from the American College of
Cardiology (ACC), the American Heart Association
(AHA), the European Society of Cardiology (ESC),
and the North American Society of Pacing and
Electrophysiology (2). While serving as the commit-
tee chair for these guidelines, I witnessed many
of my colleagues put aside their personal and pro-
fessional differences for the betterment of patients
with atrial ﬁbrillation. Collectively, we were always
focused on the goal of having congruous recom-
mendations on both sides of the proverbial pond. In
stark contrast, we have seen the clinical confusion
that has arisen from separate, often disparate. Wiener Cardiovascular Institute, Icahn
inai, New York, New York.recommendations between the United States and
Europe.
With this awareness, I began to compile and edit
The AHA Guidelines and Scientiﬁc Statements
Handbook, issued in 2009 (3). My fellow authors and I
recognized this clinical confusion and attempted to
take initial steps to clarify these disparities for the
practicing cardiologist. Through appropriate tables,
this textbook demonstrated side-by-side comparisons
of the ESC and ACC/AHA guidelines recommenda-
tions. I have personally showcased similar compari-
sons of ESC and ACC/AHA guidelines for fellows’ talks
and grand rounds across the country to provide some
clarity. However, the cardiovascular community
cannot continue to be handicapped by such makeshift
bandages for a bigger problem. Our societies need to
come together to issue joint guidelines.
A recent ACC/AHA task force statement reinforced
this idea (4). In looking to the past, the authors eval-
uated the 30-year journey of developing clinical
practice guidelines, noting that they were “fueled by a
shared sense of responsibility to translate available
evidence into clinical practice to guide cardiovascular
clinicians” (4). In looking toward the future, they
noted the importance of harmonizing ACC/AHA clin-
ical practice guidelines “with those issued by other
organizations within the United States and abroad to
maintain consistency and facilitate implementation”
(4). This cross-continental coordination of guide-
line development and issuance is crucial for deliv-
ering superior cardiovascular care across the globe.
Although there are distinct demographic, cultural,
and socioeconomic considerations in patient man-
agement, we should not use this as a divisive reason
not to harmonize our guidelines process; instead, we
should explore those differences through open lines
of communication and joint research efforts.
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to moving in the appropriate direction for patients.
This year, 2 versions of the perioperative cardio-
vascular evaluation and patient management clinical
practice guidelines were issued, but they were
created through collaborative efforts of the ACC,
AHA, and ESC. In the accompanying editorial from
the organizations (5), they explain that the revisions
were begun independently; however, the leadership
of the ACC/AHA and the ESC “recognized the
importance of scientiﬁc collaboration and writing
committee coordination for the beneﬁt of the
worldwide cardiology community.” Although the
writing committees and task force groups worked
and wrote independently on separate sides of the
Atlantic Ocean, the revised recommendations were
shared between the 2 writing committees, “so that
the rationales for any differences in recommenda-
tions could be articulated clearly” (5). This is a
step in the right direction, but we have miles to
traverse until the clinicians and patients reap
the success of these societies uniformly working
together to produce clinical practice guidelines. The
cardiovascular community needs to embrace thebiblical city of Babel before the people were given
different languages, wherein the “whole world
had 1 language and common speech” (1), when rec-
ommending care strategies for all cardiovascular
patients.
Finally, I do not want this call to action to be
misconstrued as curtailing the creative process,
because individual societies have a wonderful outlet
to put forth new ideas through scientiﬁc statements.
Within these working groups or scientiﬁc state-
ments, ideas can be appropriately disseminated to
reﬂect differing points of view. Within the Journal,
we have started to issue such statements from
councils at the College. Some concepts from these
types of statements or clinical documents may ulti-
mately make their way into clinical practice guide-
lines, which should stand alone as uniﬁed global
recommendations for cardiovascular patient care.
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